Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

PHARMACIE JEAN MICHEL GRIZARD : revenue, balance sheet and financial ratios

PHARMACIE JEAN MICHEL GRIZARD is a French company founded 17 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in GRIEGES (01290), this company of category PME shows in 2025 a net income positive of 48 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-25

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - PHARMACIE JEAN MICHEL GRIZARD (SIREN 511360083)
Indicator 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016
Revenue N/C N/C N/C N/C N/C N/C N/C N/C N/C N/C
Net income 47 673 € -93 285 € -109 601 € 1 054 € 7 808 € 72 319 € 138 649 € 164 623 € 194 413 € 186 873 €
EBITDA N/C N/C N/C N/C N/C N/C N/C N/C N/C N/C
Net margin N/C N/C N/C N/C N/C N/C N/C N/C N/C N/C

Revenue and income statement

Im Jahr 2025 erzielt PHARMACIE JEAN MICHEL GRIZARD ein positives Nettoergebnis von 48 k€. Entwicklung 2016-2025: 187 k€ -> 48 k€.

Net income (2025) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

47 673 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

Die Verschuldungsquote (= Finanzschulden / Eigenkapital x 100) beträgt 2%. Dieses niedrige Niveau spiegelt eine solide Finanzstruktur wider. Die finanzielle Autonomie (= Eigenkapital / Bilanzsumme x 100) erreicht 83%. Diese hohe Autonomie bedeutet, dass das Unternehmen den Großteil seiner Vermögenswerte durch Eigenkapital finanziert.

Debt ratio (2025) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

2.219%

Financial autonomy (2025) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

83.419%

Asset age ratio (2025) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

25.8%

Solvency indicators evolution
PHARMACIE JEAN MICHEL GRIZARD

Sector positioning

Verschuldungsgrad
2.22 2025
2023
2024
2025
Q1: 13.71
Med: 49.76
Q3: 129.07
Ausgezeichnet

Im Jahr 2025 liegt in den unteren 25% der Branche, was positiv ist das verschuldungsgrad von PHARMACIE JEAN MICHEL GRI... (2.22). Dieses Verhältnis misst das Gewicht der Schulden im Verhältnis zum Eigenkapital. Ein niedriges Verhältnis zeigt eine solide Finanzstruktur mit geringer Abhängigkeit von Gläubigern.

Finanzielle Autonomie
83.42% 2025
2023
2024
2025
Q1: 33.42%
Med: 53.71%
Q3: 72.08%
Ausgezeichnet +9 pts over 3 years

Im Jahr 2025 liegt in den oberen 25% der Branche das finanzielle autonomie von PHARMACIE JEAN MICHEL GRI... (83.4%). Dieses Verhältnis stellt den Anteil des Eigenkapitals an der Gesamtfinanzierung dar. Hohe Autonomie spiegelt finanzielle Unabhängigkeit und Fähigkeit wider, Schocks zu absorbieren.

Liquidity ratios

Die Liquiditätsquote beträgt 146.18. Das Unternehmen verfügt über 2€ liquide Mittel für jeden 1€ kurzfristiger Schulden.

Liquidity ratio (2025) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

146.176

Liquidity indicators evolution
PHARMACIE JEAN MICHEL GRIZARD

Sector positioning

Liquiditätsquote
146.18 2025
2023
2024
2025
Q1: 131.03
Med: 182.29
Q3: 258.7
Average -6 pts over 3 years

Im Jahr 2025 liegt unter dem Median der Branche das liquiditätsquote von PHARMACIE JEAN MICHEL GRI... (146.18). Dieses Verhältnis misst die Fähigkeit, kurzfristige Schulden mit Umlaufvermögen zu decken. Eine Verbesserung würde die Wettbewerbsposition stärken.

Working capital requirement (WCR) and payment terms

Der Betriebskapitalbedarf (WCR) misst die zeitliche Lücke.

Operating WCR (2025) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2025) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2025) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2025) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
PHARMACIE JEAN MICHEL GRIZARD

Positioning of PHARMACIE JEAN MICHEL GRIZARD in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 277 transactions of similar company sales in 2025, the value of PHARMACIE JEAN MICHEL GRIZARD is estimated at 757 291 € (range 513 901€ - 1 188 294€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2025
277 transactions
513k€ 757k€ 1188k€
757 291 € Range: 513 901€ - 1 188 294€
NAF 5 année 2025

Valuation method used

Net Income Multiple
47 673 € × 15.9x = 757 291 €
Range: 513 901€ - 1 188 294€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare PHARMACIE JEAN MICHEL GRIZARD with other companies in the same sector:

Frequently asked questions about PHARMACIE JEAN MICHEL GRIZARD

What is the revenue of PHARMACIE JEAN MICHEL GRIZARD ?

The revenue of PHARMACIE JEAN MICHEL GRIZARD is not publicly disclosed (confidential accounts filed with INPI).

Is PHARMACIE JEAN MICHEL GRIZARD profitable?

Yes, PHARMACIE JEAN MICHEL GRIZARD generated a net profit of 48 k€ in 2025.

Where is the headquarters of PHARMACIE JEAN MICHEL GRIZARD ?

The headquarters of PHARMACIE JEAN MICHEL GRIZARD is located in GRIEGES (01290), in the department Ain.

Where to find the tax return of PHARMACIE JEAN MICHEL GRIZARD ?

The tax return of PHARMACIE JEAN MICHEL GRIZARD is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does PHARMACIE JEAN MICHEL GRIZARD operate?

PHARMACIE JEAN MICHEL GRIZARD operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.